Carregant...
5PSQ-084 Safety and effectiveness of switching to infliximab biosimilar in digestive and rheumatological pathology
BACKGROUND: The introduction of biosimilar drugs into clinical practice allows us to maintain the effectiveness and safety of treatments, taking greater advantage of health resources PURPOSE: The objective of the study was to evaluate the safety and effectiviness of infliximab biosimilar (IFXb) in p...
Guardat en:
| Publicat a: | Eur J Hosp Pharm |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Group
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535443/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.438 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|